Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement ...
Sep 1, 2015
0
37
A new study conducted by researchers from Regenstrief Institute and the universities of South Carolina and Indiana has found that the most commonly prescribed blood pressure medications, taken for at least six months prior ...
May 1, 2023
0
13
Disrupted kidney metabolism is a key driver of progressive kidney injury in diabetic kidney disease (DKD), according to a new study led by scientists at Duke-NUS Medical School and Khoo Teck Puat Hospital in Singapore and ...
Oct 16, 2023
0
1
(HealthDay)—The new coronavirus may be a respiratory bug, but it's becoming clear that some severely ill patients sustain heart damage. And it may substantially raise their risk of death, doctors in China are reporting.
Mar 26, 2020
0
0
Adrenomedullin activity predicts which acute heart failure patients are at the greatest risk of death without diuretic treatment post-discharge, according to late breaking research presented today at Heart Failure 2019, a ...
May 25, 2019
0
1
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online ...
Dec 29, 2014
0
1
While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives—and whether they posed increased ...
Dec 18, 2020
0
2
A two-drug cocktail provided better protection against diabetes-related vision loss than a single drug during testing in rat models, a team of University of Florida Health and Dutch researchers has found.
Feb 15, 2017
0
1
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session ...
Sep 1, 2020
0
3
Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing ...
Apr 4, 2022
0
2
